Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

26.66
+0.90003.49%
Post-market: 26.660.00000.00%17:37 EDT
Volume:1.53M
Turnover:40.57M
Market Cap:3.20B
PE:-9.23
High:27.02
Open:25.77
Low:25.66
Close:25.76
Loading ...

Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care

Business Wire
·
11 Nov 2024

Avidity Biosciences’ Clinical Advancements Positioning for Regulatory Success

TIPRANKS
·
11 Nov 2024

Avidity Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
09 Nov 2024

Stock Track | Avidity Biosciences Shares Tumble After Disappointing Q3 Earnings Miss

Stock Track
·
09 Nov 2024

Avidity Biosciences Inc reports results for the quarter - Earnings Summary

Reuters
·
09 Nov 2024

Maravai Lifesciences to Buy Officinae Bio's DNA, RNA Business

MT Newswires Live
·
08 Nov 2024

Analysts Conflicted on These Healthcare Names: Molina Healthcare (MOH), Avidity Biosciences (RNA) and MoonLake Immunotherapeutics (MLTX)

TIPRANKS
·
08 Nov 2024

Avidity Biosciences: Buy Rating Affirmed Amid Steady Clinical Progress and Strategic Growth Initiatives

TIPRANKS
·
08 Nov 2024

Avidity Biosciences Reports Strong Q3 Progress and Outlook

TIPRANKS
·
08 Nov 2024

Avidity Biosciences: Strategic Advancements and Strong Pipeline Support Buy Rating

TIPRANKS
·
08 Nov 2024

ProQR: Buy Rating Affirmed on Promising RNA Base-Editing Technology and Strong Financial Position

TIPRANKS
·
08 Nov 2024

Optimistic Growth Prospects for Avidity Biosciences Amidst Financial Strength and Strategic Developments

TIPRANKS
·
08 Nov 2024

Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
08 Nov 2024

Avidity Biosciences Q3 EPS $(0.65) Beats $(0.73) Estimate, Sales $2.34M Miss $4.27M Estimate

Benzinga
·
08 Nov 2024

Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test

Business Wire
·
08 Nov 2024

Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights

PR Newswire
·
08 Nov 2024

ProQR Announces Third Quarter 2024 Operating and Financial Results

GlobeNewswire
·
07 Nov 2024

Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for

Zacks
·
06 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Nov 2024

Ionis Pharmaceuticals: FDA accepts for review NDA for donidalorsen

TIPRANKS
·
04 Nov 2024